文献速递糖尿病

高血糖高钠高渗状态:HHS的主要亚型及其临床与诊断特征

Hyperglycemic Hypernatremic Hypertonic State: A Predominant HHS Subtype and Its Clinical and Diagnostic Features.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该回顾性研究纳入2018至2024年单中心连续174例成人糖尿病HHS患者,发现按校正钠定义的高钠血症占95.4%(166/174),远超实测钠定义的8%(14/174);有效血清渗透压>300 mOsm/L诊断HHS比总血清渗透压>320 mOsm/L更敏感,且65.5%(114/174)合并DKA。

要点

  • 按校正钠定义的高钠血症在HHS中占95.4%(166/174),提示其为HHS主要亚型。
  • 实测钠>145 mmol/L的高钠血症仅占8%(14/174)。
  • 有效血清渗透压>300 mOsm/L诊断HHS比总血清渗透压>320 mOsm/L更敏感。

核心结论

  • 以校正钠定义的高钠血症在HHS中高度流行且具有临床相关性,因校正钠更好地反映真实自由水缺失。
  • HHS管理应包括评估实测和校正钠,采用有效血清渗透压>300 mOsm/L作为更敏感的诊断标准,并重新评估显著酮血症和酸血症的排除标准。

研究设计与样本

  • 回顾性研究,纳入2018至2024年单中心连续成人糖尿病HHS住院患者174例。
  • 评估实测和校正钠、自由水缺失、计算有效血清渗透压、计算总血清渗透压以及合并DKA和代谢性酸中毒情况。

主要发现

  • 174例HHS患者中,基于实测钠(>145 mmol/L)的高钠血症不常见(14/174,8%)。
  • 基于高血糖校正钠的高钠血症高度流行(166/174;95.4%),提示HHS伴高钠血症是HHS的主要亚型。
  • 有效血清渗透压>300 mOsm/L诊断HHS比总血清渗透压>320 mOsm/L更敏感。
  • 65.5%(114/174)的HHS病例合并DKA,提示传统HHS诊断中排除显著酮血症和酸血症可能需重新考虑。

关键数值与推荐

  • 实测钠>145 mmol/L定义的高钠血症患病率为8%(14/174)。
  • 校正钠定义的高钠血症患病率为95.4%(166/174)。
  • 有效血清渗透压>300 mOsm/L诊断HHS的敏感性高于总血清渗透压>320 mOsm/L。
  • 合并DKA的比例为65.5%(114/174)。

临床怎么用

  • HHS管理应包括评估实测和校正钠。
  • 采用有效血清渗透压>300 mOsm/L作为更敏感的HHS诊断标准。
  • 重新评估HHS诊断中显著酮血症和酸血症的排除标准。
  • 这些改进可能提高诊断准确性并使HHS的液体管理更个性化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Hyperglycemic hyperosmolar state (HHS) with concurrent hypernatremia is an emerging and under-investigated subtype of HHS. OBJECTIVE: To investigate the clinical characteristics, prevalence, and diagnostic parameters of this under-recognized HHS subtype. METHODS: We conducted a retrospective study of consecutive adults with diabetes admitted with HHS from 2018 to 2024 at a single institution. We assessed the measured and corrected sodium, free water deficit, calculated effective serum osmolarity, calculated total serum osmolarity, and coexisting diabetic ketoacidosis (DKA) and metabolic acidosis. RESULTS: Among 174 patients with HHS, hypernatremia based on measured sodium (> 145 mmol/L) was uncommon (14/174, 8%), consistent with prior reports. However, hypernatremia based on corrected sodium for hyperglycemia was highly prevalent (166/174; 95.4%), suggesting that HHS with hypernatremia is the predominant subtype of HHS. Effective serum osmolarity > 300 mOsm/L was more sensitive than total serum osmolarity > 320 mOsm/L for diagnosing HHS. Additionally, 65.5% (114/174) of HHS cases had concurrent DKA, suggesting that the traditional exclusion of significant ketonemia and acidemia in HHS diagnosis may warrant reconsideration. CONCLUSION: HHS with hypernatremia, defined by corrected sodium, is highly prevalent and clinically relevant, as corrected sodium better reflects the true free water deficit. HHS management should include evaluating both measured and corrected sodium, adopting effective serum osmolarity > 300 mOsm/L as a more sensitive diagnostic criterion, and reevaluating the exclusion criteria of significant ketonemia and acidosis. These refinements may enhance diagnostic accuracy and enable more personalized fluid management in HHS.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Cao S, Cao S. Hyperglycemic Hypernatremic Hypertonic State: A Predominant HHS Subtype and Its Clinical and Diagnostic Features. J Clin Endocrinol Metab. 2026. PMID: 40690721. doi:10.1210/clinem/dgaf422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。